Companies / Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp.

Nasdaq: KTTACIK 1841330MIAMI BEACH, FL

Financials · FY2022

Revenue$486.6K
Net income$-20.43M
Total debt—
Cash$50.40M
Diluted EPS$-2.91
Shares outstanding33.4M

Ownership

33.4M shares outstanding · as of May 13, 2026
38.9%Institutions
Ownership
Institutions38.93%13,007,502
Public float61.07%20,406,946

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 2

View all →
Insider% of sharesShares
Novak Alfred JDirector
——
Steinman LawrenceDirector
——

Institutional holders 26

View all →
HolderValue% of shares
Squadron Master Fund LP$2.71M6.28%
Vivo Capital, LLC$2.71M6.28%
Ameriprise Financial Inc$2.49M5.78%
Janus Henderson Group PLC$1.56M6.28%
Adage Capital Partners Gp, L.L.C.$1.56M6.28%
Cable Car Capital, LP$645.0K1.50%
Acuta Capital Partners, LLC$580.5K1.35%
Stempoint Capital LP$458.1K1.06%
AdvisorShares Investments LLC$393.1K0.91%
Stonepine Capital Management, LLC$354.8K0.82%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
May 1, 2026Novak Alfred J
Director
GrantStock Option (right to buy)—+153K
152,783
0.46% of shares
low
May 1, 2026Steinman Lawrence
Director
GrantStock Option (right to buy)—+153K
152,783
0.46% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Adage Capital Management, L.P.Passive13G———
CVI Investments, Inc.Passive13G/A———
Squadron Master Fund LPPassive13G/A———
Ameriprise Financial IncPassive13G———
Coastlands Capital LPPassive13G———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
KTTACommon StockEquity70261F202BBG01018ZGY8